New Research Highlights Non-Immune Cells' Role in mRNA Vaccine Effectiveness

A study from the Icahn School of Medicine at Mount Sinai, published in Nature Biotechnology, suggests that non-immune cells significantly influence mRNA vaccine efficacy. This preclinical research challenges existing assumptions about how these vaccines generate immunity. The findings also introduce a novel technology to enhance mRNA drug expression, potentially improving future mRNA therapies for various diseases.